S Asra Husain1, Marty Skemp Brown1, Martha A Maurer1. 1. WHO Collaborating Center for Pain Policy and Palliative Care, Pain and Policy Studies Group, University of Wisconsin, 1300 University Avenue, 6152 MSC, Madison, WI 53706, United States of America .
Abstract
OBJECTIVE: To determine whether national drug control laws ensure that opioid drugs are available for medical and scientific purposes, as intended by the 1972 Protocol amendment to the 1961 Single Convention on Narcotic Drugs. METHODS: The authors examined whether the text of a convenience sample of drug laws from 15 countries: (i) acknowledged that opioid drugs are indispensable for the relief of pain and suffering; (ii) recognized that government was responsible for ensuring the adequate provision of such drugs for medical and scientific purposes; (iii) designated an administrative body for implementing international drug control conventions; and (iv) acknowledged a government's intention to implement international conventions, including the Single Convention. FINDINGS: Most national laws were found not to contain measures that ensured adequate provision of opioid drugs for medical and scientific purposes. Moreover, the model legislation provided by the United Nations Office on Drugs and Crime did not establish an obligation on national governments to ensure the availability of these drugs for medical use. CONCLUSION: To achieve consistency with the Single Convention, as well as with associated resolutions and recommendations of international bodies, national drug control laws and model policies should be updated to include measures that ensure drug availability to balance the restrictions imposed by the existing drug control measures needed to prevent the diversion and nonmedical use of such drugs.
OBJECTIVE: To determine whether national drug control laws ensure that opioid drugs are available for medical and scientific purposes, as intended by the 1972 Protocol amendment to the 1961 Single Convention on Narcotic Drugs. METHODS: The authors examined whether the text of a convenience sample of drug laws from 15 countries: (i) acknowledged that opioid drugs are indispensable for the relief of pain and suffering; (ii) recognized that government was responsible for ensuring the adequate provision of such drugs for medical and scientific purposes; (iii) designated an administrative body for implementing international drug control conventions; and (iv) acknowledged a government's intention to implement international conventions, including the Single Convention. FINDINGS: Most national laws were found not to contain measures that ensured adequate provision of opioid drugs for medical and scientific purposes. Moreover, the model legislation provided by the United Nations Office on Drugs and Crime did not establish an obligation on national governments to ensure the availability of these drugs for medical use. CONCLUSION: To achieve consistency with the Single Convention, as well as with associated resolutions and recommendations of international bodies, national drug control laws and model policies should be updated to include measures that ensure drug availability to balance the restrictions imposed by the existing drug control measures needed to prevent the diversion and nonmedical use of such drugs.
Authors: Odontuya Davaasuren; Jan Stjernswärd; Mary Callaway; Gombodoroj Tsetsegdary; Robert Hagan; Salik Govind; Chimedtseren Munkhdelger; Frank D Ferris; Mary S Wheeler Journal: J Pain Symptom Manage Date: 2007-05 Impact factor: 3.612
Authors: Marie-Josephine Seya; Susanne F A M Gelders; Obianuju Uzoma Achara; Barbara Milani; Willem Karel Scholten Journal: J Pain Palliat Care Pharmacother Date: 2011
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702